Clinical trial
Safety and Efficacy of a Closed-loop Oxygen Control for High Flow Nasal Therapy in ICU Patients: a Randomized Cross-over Study (The HILOOP Study)
NCT04965844 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of a Closed-loop Oxygen Control for High Flow Nasal Therapy in ICU Patients: a Randomized Cross-over Study (The HILOOP Study)
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 27, 2021
- Completion date
- August 10, 2021
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory failure, high flow nasal cannula, hyperoxemia, hypoxemia, oxygen therapy, respiratory insufficiency